SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-20-008730
Filing Date
2020-04-13
Accepted
2020-04-13 16:35:53
Documents
5
Period of Report
2020-05-15
Effectiveness Date
2020-04-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A nc10010435x2_def14a.htm DEF 14A 1075871
2 logo_seelostherapeutics.jpg GRAPHIC 50919
3 nc10010435x2_proxycard001.jpg GRAPHIC 1322791
4 nc10010435x2_proxycard002.jpg GRAPHIC 1335537
5 sig_rajmehra.jpg GRAPHIC 10357
  Complete submission text file 0001140361-20-008730.txt   4632938
Mailing Address 300 PARK AVENUE NEW YORK NY 10017
Business Address 300 PARK AVENUE NEW YORK NY 10017 (646) 998-6475
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-22245 | Film No.: 20789085
SIC: 2834 Pharmaceutical Preparations